We hosted an information session to discuss the key issues identified in the consultation paper and outlined the proposed regulatory options to address these issues. The session included a moderated panel discussion, providing stakeholders with the opportunity to ask questions and seek clarification. The session will be recorded and made available on the TGA website and YouTube.
Speakers
Avinash Clarke, Assistant Secretary, Complementary and OTC Branch, TGA
Lisa Kerr, Assistant Secretary, Laboratories Branch, TGA
